Skip to main content
Clinical and Translational Medicine
Fig. 3 | Clinical and Translational Medicine

Fig. 3

From: The novel llama-human chimeric antibody has potent effect in lowering LDL-c levels in hPCSK9 transgenic rats

Fig. 3

The affinity test for the four VHHs/hPCSK9 interaction. A 6 or 7-points, double fold dilution of these VHH-based proteins were injected to bind with the hPCSK9. Each colored line represents one concentration of the VHH proteins. The black lines represent the automatic fitting curves by the built-in evaluation software. The horizontal axis represents the timeline, and the vertical axis represents the relative response unit of the VHH/hPCSK9 interaction. The VHH protein injection time point was automatically set as 0 s by the built-in evaluation software

Back to article page